Page last updated: 2024-11-06

prednisolone and Color Vision Defects

prednisolone has been researched along with Color Vision Defects in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Color Vision Defects: Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Turaka, K1
Kietz, D1
Krishnamurti, L1
Mitchell, E1
Scanga, H1
Fu, VL1
Sylvester, C1
Kupersmith, MJ1
Langer, R1
Mitnick, H1
Spiera, R1
Spiera, H1
Richmond, M1
Paget, S1

Trials

1 trial available for prednisolone and Color Vision Defects

ArticleYear
Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
    The British journal of ophthalmology, 1999, Volume: 83, Issue:7

    Topics: Adrenal Cortex Hormones; Aged; Color Vision Defects; Contrast Sensitivity; Female; Follow-Up Studies

1999

Other Studies

1 other study available for prednisolone and Color Vision Defects

ArticleYear
Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2014, Volume: 18, Issue:4

    Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Arrestin; Autoantibodies;

2014